[1] Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation [J]. Nat Rev Immunol, 2015, 15(1)∶30-44 [2] Staab EB, Sanderson SD, Wells SM, et al. Treatment with the C5a receptor/CD88 antagonist PMX205 reduces inflammation in a murine model of allergic asthma [J]. Int Immunopharmacol, 2014, 21(2)∶293-300 [3] Cairo G, Recalcati S, Mantovani A, et al. Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype [J]. Trends Immunol, 2011, 32(6)∶241-247 [4] Lam RS, O'Brien-Simpson NM, Lenzo JC, et al. Macrophage depletion abates Porphyromonas gingivalis-induced alveolar bone resorption in mice [J]. J Immunol, 2014, 193(5)∶2349-62 [5] 侯玉帛,刘歆婵,李格格,等.牙龈蛋白酶对M1型巨噬细胞表达抑菌细胞因子的调控作用[J].口腔医学研究,2016,32(11)∶1122-1126 [6] Gordon S, Plüddemann A, Martinez Estrada F. Macrophage heterogeneity in tissues: phenotypic diversity and functions [J]. Immunol Rev, 2014, 262(1)∶36-55 [7] Rückerl D, Allen JE. Macrophage proliferation, provenance, and plasticity in macroparasite infection [J]. Immunol Rev, 2014, 262(1)∶113-133 [8] Sica A, Erreni M, Allavena P, et al. Macrophage polarization in pathology [J]. Cell Mol Life SCI, 2015, 72(21)∶4111-4126 [9] Tabas I, Glass CK. Anti-inflammatory therapy in chronic disease: challenges and opportunities [J]. Science, 2013, 339(6116)∶166-172 [10] Abe T, Hosur KB, Hajishengallis G, et al. Local complement-targeted intervention in periodontitis: proof-of-concenpt using a C5a receptor antagonist [J]. J Immunol, 2012, 196∶5442-4558 [11] Jain U, Woodruff TM, Stadnyk AW. The C5a receptor antagonist PMX205 ameliorates experimentally induced colitis associated with increased IL-4 and IL-10 [J]. Br J Pharmacol, 2013, 168(2)∶488-501 [12] Delisle Milton RC, Milton SC, Chamberlin AR. Improving the Fmoc Solid Phase Synthesis of the Cyclic Hexapeptide Complement C5a Antagonist, PMX205 [J]. Int J Pept Res Ther, 2011, 17(4)∶337-342 |